6 completed. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Peripheral Nerve Injuries: new trials by email Literature Review of Peripheral Nerve Injuries trials Research Report on Peripheral Nerve Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury IncobotulinumtoxinA, Placebo - Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury | Phase 2 | Completed | Merz Therapeutics GmbH | 123 | 2023-11-22 | 2026-05-05 |
| Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries NTX-001 - Peripheral Nerve Injuries | Phase 2 | Completed | Neuraptive Therapeutics Inc. | 51 | 2020-09-25 | 2026-10-15 |
| The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration. Electrical Stimulation, Sham Stimulation - Peripheral Nerve Injuries, Sensory Deficit | Phase 2 / Phase 3 | Completed | University of Alberta | 38 | 2017-10-01 | 2024-09-19 |
| Study in Neuropathic Pain Patients With Peripheral Nerve Injury GW856553, PLACEBO - Pain, Neuropathic | Phase 2 | Completed | GlaxoSmithKline | 168 | 2009-08-01 | 2017-02-17 |
| Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain CAPNP, 50 ug/cm2 capsaicin patch, CAPNP, 100 ug/cm2 capsaicin patch, 0.075% capsaicin cream - Peripheral Nerve Injury, Postherpetic Neuralgia | Phase 1 / Phase 2 | Completed | Samyang Biopharmaceuticals Corporation | 60 | 2009-02-01 | 2017-05-01 |
| Comparing Primary With Secondary Repair of Based on Electrodiagnostic Assessment and Clinical Examination primary repair, secondary repair - Peripheral Nerve Injury | Phase 2 | Completed | Isfahan University of Medical Sciences | 46 | 2008-03-01 | 2010-05-20 |
Neuralgia, Postherpetic (2) · Neuralgia (1)
Nervous System Diseases (6) · Neuromuscular Diseases (6) · Peripheral Nervous System Diseases (6) · Trauma, Nervous System (6) · Wounds and Injuries (6) · Neurologic Manifestations (3) · Pain (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Neuralgia (2)
6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide (1) · Botulinum Toxins, Type A (1) · Electric Stimulation (1) · incobotulinumtoxinA (1)
GlaxoSmithKline (1) · Isfahan University of Medical Sciences (1) · Merz Therapeutics GmbH (1) · Neuraptive Therapeutics Inc. (1) · Samyang Biopharmaceuticals Corporation (1) · University of Alberta (1)
Spain (2) · Australia (1) · Bulgaria (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Iran (1) · Norway (1) · Poland (1) · Russia (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Julie Beveridge, MD (1) · K Ming Chan, MB ChB (1) · Seth Schulman, MD (1)